Odisha's Ambitious Pharma Leap: New Policy to Transform State into Eastern Hub
Odisha's government unveiled its Pharmaceutical and Medical Devices Policy-2025 at the Pharma Summit-2025, aiming for a Rs 25,000 crore investment and 1 lakh job creation by 2030. The policy offers subsidies and seeks to make Odisha a hub for pharmaceuticals and medical devices with emphasis on green manufacturing and local entrepreneurship.
- Country:
- India
The Odisha government introduced the Pharmaceutical and Medical Devices Policy-2025 at the Odisha Pharma Summit-2025, ushered by Chief Minister Mohan Charan Majhi. The policy promises a financial influx of Rs 25,000 crore and aims to generate employment for 1 lakh people by 2030.
Industries Department Additional Chief Secretary Hemant Sharma pointed out that with India importing 85% of its medical devices, the sector holds immense potential. Odisha, therefore, seeks to leverage this by fostering new pharmaceutical and medical device units in the next five years.
The policy envisions Odisha as a pharmaceutical hub by promoting investment, employment, innovation, and green manufacturing. It includes subsidies on land and power infrastructure and supports research excellence, industry-academia collaborations, and regulatory facilitation to attract investments.
ALSO READ
IRDAI being empowered to disgorge wrongful gains made by insurers and distribute them to affected insurance policyholders: FM in Lok Sabha.
GST council secretariat is monitoring complaints regarding GST cut benefit not being passed on to policyholders, says Finance Minister.
Tikaram Jully Criticizes Central Government Over Name Change and Policy Missteps
Wall Street Braces for a Tumultuous Tuesday: Economy, Jobs, and Fed Policy in Focus
U.S. Stock Futures Dip Amid Caution Over Upcoming Jobs Report and Policy Shifts

